Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Vaccines, Blood & Biologics

Record of Telephone Conversation, July 26, 2013 - Q-Pan

Submission Type: BLA
Submission ID: 125419/0
Office: OVRR

Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted

ID Biomedical Corporation of Quebec

Telecon Date/Time: 26-Jul-2013 10:30 AM Initiated by FDA? Yes

Telephone Number: 610-787-3435

Communication Categorie(s):
1. Information Request


Telecon Summary:
IR regarding a subject with Cronkhite-Canada syndrome

FDA Participants: Carmen Collazo-Custodio, Andrea James, Kirk Prutzman, Jeremy Wally

Non-FDA Participants: Michael Schwartz

Telecon Body:
CBER requested the Case Report Form and source documents for subject number 6229. CBER also asked GSK to prepare a narrative of the company’s assessment of the diagnosis of Cronkhite-Canada syndrome in this subject. CBER also clarified that our review is still ongoing and we may have additional request(s) for information in the near future.

Page Last Updated: 05/05/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English